Three Investing Myths – Debunked

When it comes to investing, we’ve been lied to for nearly a century.

We’ve been told that if we take the investment path that’s “tried and true,” we’ll be able to retire comfortably, right on time.

But this couldn’t be further from the truth.

And today…

Read More

Tags: Early stage-investing Stock market

Skin in the Game

Skin in the game.

Some investment newsletters have it...

Other don’t.

You see, while some newsletters make a big show about investing in the ideas they recommend, others insist on staying on the sidelines.

For many newsletters—and for investors like you—this topic inspires great debate:

Newsletters that invest could be…

Read More

Tags: Investment newsletters

Read this before tomorrow...

You’ve already read about Wayne’s story, and about mine...

So today I want to tell you a little story about someone else.

This guy was in even worse financial shape than I was, but he still managed to transform his life.

He started out with nothing—he was really in a…

Read More

Get Rich With Just $100?

Several weeks ago, I caught a game with some buddies at Yankee Stadium.

After buying tickets, some BBQ from Brother Jimmy’s, and a few rounds of Buds, we spent about $100 each.

The Yankees won and we had a blast.

Back in the office early the next morning, I reviewed…

Read More

Tags: Equity crowdfunding The jobs-act

It's Not Your Fault!

When it comes to investing, we’ve been lied to for nearly a century:

We’ve been told that there are only a few different ways to invest…

And we’ve been told that if we take the path that’s “tried and true,” we’ll be able to retire comfortably, right on time.

Unfortunately,…

Read More

"Where Should We Send Your Money?"

Hey guys, Matt Milner here.

This is an actual e-mail I received a few months ago (I blurred out the details for privacy reasons):

And over the past…

Read More

[Forecast] 98% Chance of Profits

From June 2014 to June 2015, the biotechnology sector was on fire…

In just 12 months, the NASDAQ Biotech Index (NBI) soared by 53%.

The next year, however, wasn’t nearly as lucrative:

From June 2015 up until today, the NBI plummeted by about 25%. Essentially, it gave back all its…

Read More

Tags: Biotech